At least 20 pharmaceutical and biotech companies are competing to launch a safer and more effective weight-loss pill in a bid to conquer the billion-dollar market for obesity treatments. Aside from striving to meet the FDA's high standards for approval, drug developers are also examining the brain's responses to weight loss.

Related Summaries